A Terapia Gênica de Parkinson Agora no Ensaio da Fase 2, VY-AADC, Continua a Mostrar Benefícios Motores, Diz Voyager

JULY 20, 2018 - Parkinson’s Gene Therapy Now in Phase 2 Trial, VY-AADC, Continues to Show Motor Benefits, Voyager Says.